{
    "title": "FDA OKs new drug to treat all forms of hepatitis C",
    "url": "https://www.dailymail.co.uk/wires/ap/article-4758926/FDA-OKs-new-drug-treat-forms-hepatitis-C.html",
    "date": "2017-08-03",
    "keywords": [
        "treatment",
        "drug",
        "hepatitis",
        "c",
        "virus",
        "percent",
        "administration",
        "cirrhosis",
        "disease",
        "market",
        "liver",
        "maryvet",
        "food",
        "damage",
        "insurance",
        "coverage",
        "pill",
        "combination",
        "inc",
        "type",
        "merck",
        "co",
        "gilead",
        "leverage",
        "pricey",
        "photo",
        "abbvie",
        "mavyret",
        "liverdestroying",
        "richard",
        "mackcourtesy",
        "control",
        "prevention",
        "failure",
        "cancer",
        "transplant",
        "death",
        "year",
        "half",
        "government",
        "health",
        "cost",
        "course",
        "harvoni",
        "chicago",
        "illinois",
        "price",
        "entrant",
        "exchange",
        "spokesman",
        "morry",
        "smulevitz",
        "company",
        "medicare",
        "medicaid",
        "key",
        "share",
        "analyst",
        "raffat",
        "adult",
        "blood",
        "kidney",
        "glecaprevir",
        "pibrentasvir",
        "day",
        "side",
        "headache",
        "fatigue",
        "skin",
        "b",
        "linda",
        "johnson",
        "lindaj_onpharma"
    ],
    "category": [
        "wires",
        "ap"
    ]
}